Cargando…
Overexpression of IL-7 enhances cisplatin resistance in glioma
Cisplatin is one of the most commonly used chemotherapeutic agents for glioma patients. In this study, array comparative genomic hybridization (aCGH) was used to identify genes associated with cisplatin resistance in a human glioma cell line. The cisplatin-resistant U251/CP2 cell line was derived by...
Autores principales: | Cui, Lei, Fu, Jun, Pang, Jesse Chung-Sean, Qiu, Zhi-Kun, Liu, Xiao-Mei, Chen, Fu-Rong, Shi, Hong-Liu, Ng, Ho-Keung, Chen, Zhong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364789/ https://www.ncbi.nlm.nih.gov/pubmed/22415136 http://dx.doi.org/10.4161/cbt.19592 |
Ejemplares similares
-
Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011) -
Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated with Malignant Progression but Predicted Longer Survival
por: Yao, Yu, et al.
Publicado: (2013) -
Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ
por: Qiu, Xia, et al.
Publicado: (2016) -
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS-mutated lung cancer cells
por: Wang, Mei, et al.
Publicado: (2022) -
TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production
por: Han, Xiu-guo, et al.
Publicado: (2018)